Savara Inc. · 1 day ago
Accounts Payable Specialist (remote)
United States
Full-time
Remote
New Grad, Entry Level
$32.70/hr - $42.30/hrSavara Inc. is a clinical stage biopharmaceutical company focused on rare respiratory diseases. They are seeking an Accounts Payable Specialist to manage the accounts payable process and ensure accurate financial reporting while collaborating with various teams within the organization.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Run the entire accounts payable process including vendor invoice intake, new vendor set up, manager approvals and payments
Triage and resolve vendor inquiries and payment exception while maintaining vendor relationships
Field questions from team members about vendor invoices and payments
Work directly with accounting team to help coordinate and support the forecasting of cash outflow
Review and process employee expense reports including corporate credit card transactions
Work with accounting and finance on month/quarter/year end close process
Other tasks as assigned
Qualification
Required
Associate degree or higher in accounting
Experience using Microsoft Suite products, specifically Excel
Experience using NetSuite
Strong understanding of the accounts payable cycle
Ability to manage multiple tasks with strong organization, follow-though, and accuracy
Effective communication skills, both written and verbal
Preferred
General ledger accounts payable experience, ideally in multi-entity and international environments
Experience with Concur
Experience with working in an environment that is Sarbanes Oxley compliant
Experience in the Biotech industry
Benefits
Highly competitive medical, dental, and vision coverage
Flexible Spending Account for health care and dependent care expenses and Health Savings Account
Paid time off and paid holidays, including Dec 24-Jan 1
Paid parental leave
401(k) with highly competitive match
Life, AD&D, STD and LTD insurance coverage
Company
Savara Inc.
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases.
Founded in 2007
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$668.6MKey Investors
RTW InvestmentsHercules CapitalSilicon Valley Bank
2025-10-29Post Ipo Equity· $149.5M
2025-10-29Post Ipo Debt· $75M
2025-03-26Post Ipo Debt· $30M
Leadership Team
Matthew Pauls
Chief Executive Officer
Kate McCabe
Chief Legal Officer
Recent News
2025-12-17
Company data provided by crunchbase